02.08.2018 • News

Moody’s Upgrades Covestro’s Rating

Moody’s Upgrades Covestro’s Rating (c) Covestro
Moody’s Upgrades Covestro’s Rating (c) Covestro

Due to the engineering plastics producer’s sustained good earnings situation and the significantly improved balance sheet structure, international ratings agency Moody's has reassessed the credit rating for Covestro, raising  it from Baa2 to Baa1 with a stable outlook.

Since Moody's first Baa2 rating in October 2015, Covestro has improved its debt ratio, expressed by total net debt to EBITDA for the last 12 months, from 2.2x to 0.5x.

Chief financial officer, Thomas Toepfer, said the improved rating is the result of a disciplined financial strategy, noting that the company has succeeded in using its positive business development of recent years to consistently reduce debt and sustainably strengthen its balance sheet. The Moody’s upgrade “reflects the capital markets’ increased confidence in our financial strength,” Toepfer said.

The Leverkusen-based former Bayer MaterialScience meanwhile has revised its financial target for full year 2018 upward. This follows a strong second quarter in which sales revenue added more than 10% to nearly €4 billion, EBITDA gained 16% to €985 million and net income advanced by nearly a quarter to €604 million.
 

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read